The FDA first approved tegaserod oral tablets (Zelnorm, Novartis) on July 24, 2002, for the short-term treatment of women with IBS-C. Safety and efficacy were not demonstrated in males, as they ...

The FDA originally approved tegaserod (Zelnorm, Sloan Pharmaceuticals) in 2002 for the treatment of IBS-C in women. However, Novartis, the drug’s previous manufacturer, voluntarily pulled ...

More than half of patients with irritable bowel syndrome-mixed bowel pattern treated with tegaserod reported improved symptoms at least 75% of the time.

LOUISVILLE, Ken., April 1, 2019 /PRNewswire/ -- US WorldMeds has announced that Sloan Pharma, S.a.r.l., a subsidiary of US WorldMeds Holdings, LLC, has received approval from the U.S. Food and ...

A randomized, placebo-controlled trial of 2,660 women found that tegaserod (Zelnorm) was effective for initial treatment and during recurrence of irritable bowel syndrome (IBS) flares (Gut. 2005 ...

Zelnorm (tegaserod; Alfasigma) is available again for the treatment of irritable bowel syndrome with constipation (IBS-C) in adult women <65 years of age.

US WorldMeds announced that the Food and Drug Administration (FDA) has approved the reintroduction of Zelnorm (tegaserod) for the treatment of irritable bowel syndrome with constipation (IBS-C) in ...

Gatifloxacine, tegaserod, deanxit may also be banned in India soon: Ramesh Shankar, Mumbai Monday, January 17, 2011, 08:00 Hrs [IST] Even as the controversial drugs nimesulide (for use of below 12 ...